Forskarstuderande vid enheten för kirurgi och onkologiRegistrerade doktorander Ebba Asplund Liquid biopsy before and after surgery for pancreatic cancer E-post: ebba.asplund@ki.se Ruth Baumgartner Clinical and tumour biological aspects of patients undergoing hepatectomy for primary and srcondary liver tumours E-post: ruth.baumgartner@ki.seErik Bergquist Pancreatic cancer – early diagnostics and surgical treatment of premalignant lesions E-post: erik.bergquist@ki.sePeter Elbe Doktorand E-post: peter.elbe@ki.seAngeline Enton Raj Outcomes of multimodality treatment of esophageal adenocarcinoma based on immunological subtypes E-post: angeline.enton.raj@ki.seTruls Gråberg Doktorand E-post: truls.graberg@ki.se Beate Gündel Investigation of pancreatic cancer aided by 3D-culture models E-post: beate.gundel@ki.seAnders Holmén Nutrition and health-related quality of life after multimodality treatment of gastroesophageal cancer E-post: anders.holmen@ki.seBiying Huang Peritoneal disease in gastric cancer E-post: biying.huang@ki.seMagnus Konradsson Gastric outlet obstruction after esophagectomy: Epidemiology , diagnosis and treatment E-post: magnus.konradsson@ki.se Patrik Larsson The impact of heart disease on patients with malignant and premalignant pancreatic diseases E-post: patrik.larsson@ki.seLinnéa Malgerud Personalised pancreatic cancer: Individualized, evidence based treatment E-post: linnea.malgerud@ki.seHenrik Maltzman Optimizing outcomes for gastroesophageal cancer in the era of endoscopic treatment E-post: henrik.maltzman@ki.seAnn Morgell Preemptive pancreatic surgery E-post: ann.morgell@ki.seNora Norén Molecular subtypes, therapeutic approach and outcome in gastroesophageal cancer E-post: nora.noren@ki.seMarcus Nömm Cognitive impact associated with surgery for gastric and esophageal cancer E-post: marcus.nomm@ki.se Halla Sif Ólafsdóttir Radiotherapy in the Treatment of Oesophageal Cancer E-post: halla.sif.olafsdottir@ki.seDawid Rutkowski A deep learning-based radiogenomic approach to assess tumour characteristics in pancreatic cancer E-post: dawid.rutkowski@ki.seWiktor Rutkowski Tumor-related fecal dysbiosis in pancreatic cancer patient E-post: wiktor.rutkowski@ki.seGabriel Saliba The role of molecular subtypes and biomarkers in gastroesophageal adenocarcinoma for individually tailored treatment and increased overall survival E-post: gabriel.saliba@ki.seCaroline Salmén Tumor-biology of liver metastases: Clinical and clinicopathological studies E-post: caroline.salmen@ki.seJohanna Samola Winnberg Hereditary ventricular cancer E-post: johanna.samola.winnberg@ki.seDaniel Selin Aspects of acute pancreatitis – studies on etiology and outcome E-post: daniel.selin@ki.se Sara Söderqvist Replacement Growth in Pancreatic Cancer and its Liver Metastases: Live Cell Studies and Clinical Connections E-post: sara.soderqvist@ki.seJohn Thörling Aspects of glucose metabolism in acute surgical and orthopedic patients E-post: john.thorling@ki.se Annika Viljamaa Liver Metastases Encapsulation: Cellular Players and Molecular Mechanisms E-post: annika.viljamaa@ki.seLinn Christina Westin Inguinal hernia - optimizing surgical treatment. E-post: linn.westin@ki.seHannes Wållgren Robotic-assisted contra open resection for suspected or confirmed gallbladder cancer E-post: hannes.wallgren@ki.se
